Onco Wiki / Bandera roja

History of Opisthorchis viverrini infection (positive stool ova / microscopy, positive se...

Vista determinista de la entidad fuente YAML. La autoridad clínica sigue con los ID de fuente citados y estado de firma del revisor.

IDRF-OPISTHORCHIS-CHOLANGIO-PREVENTION
TipoSeñal de alerta
Situaciónreviewed 2026-05-18 | pending_clinical_signoff
EnfermedadesDIS-CHOLANGIOCARCINOMA
FuentesSRC-IARC-MONO-100B-2012 SRC-NCCN-HCC-2025

Origen de la bandera roja

DefiniciónHistory of Opisthorchis viverrini infection (positive stool ova / microscopy, positive serology, or documented endemic-region exposure with raw / undercooked freshwater-fish consumption) in an individual without a current cholangiocarcinoma diagnosis. IARC Group 1 carcinogen (O. viverrini) — established etiological driver of intrahepatic cholangiocarcinoma in the Mekong basin (Northeast Thailand, Laos, Vietnam, Cambodia). Praziquantel cures active infection but does NOT reverse chronic biliary-tract inflammation / fibrosis from prior burden; lifelong hepatobiliary surveillance (liver US + CA 19-9 every 12 months from age 40 in heavily-exposed cohorts) is the dominant prevention modality. Prevention-persona RedFlag (§20 ratification 2026-05-18).
Dirección clínicainvestigación
Categoríaotros

Lógica de activación

{
  "any_of": [
    {
      "finding": "opisthorchis_viverrini_history",
      "value": "positive"
    },
    {
      "finding": "opisthorchis_viverrini_ova_stool",
      "value": "positive"
    },
    {
      "finding": "opisthorchis_viverrini_serology",
      "value": "positive"
    }
  ],
  "type": "lab_value"
}

Notas

Prevention-persona RedFlag for O. viverrini-driven cholangiocarcinoma prevention. Fires on any documented exposure history with confirmatory testing. Engine routes to PreventionPlan recommending praziquantel (if active infection) + lifelong hepatobiliary surveillance (US + CA 19-9 q12mo from age 40 in heavily-exposed cohorts). STUB pending Co-Lead review. Cancer scope: anchored to DIS-CHOLANGIOCARCINOMA. Northeast Thailand has the world's highest cholangiocarcinoma incidence (up to 90 per 100K) — attributable fraction in endemic regions exceeds 50%. Geographic context: relevant for Mekong-region diaspora, refugees, travelers, and adoptees. Companion to RF-CLONORCHIS-CHOLANGIO-PREVENTION (East Asian liver-fluke pathway, biologically similar mechanism).

Utilizado por

Indicación

Señal de alerta